Joshua S. Prince - Dec 31, 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Operating Officer
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Dec 31, 2024
Transactions value $
$8,300
Form type
4
Date filed
1/13/2025, 05:40 PM
Previous filing
Jul 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $8.3K +3.31K +123.92% $2.51 5.98K Dec 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).